13 Jun 2013

RAPID™-PsA study highlights burden of psoriatic arthritis and showed that patients treated with certolizumab pegol reported improvements in pain and fatigue, and increased productivity at work and within the home

Read More
13 Jun 2013

UCB announces new results from phase 2b open-label extension study evaluating the long-term effects of epratuzumab in SLE

Read More
12 Jun 2013

Transparency notification of Vanguard Health Care Fund

Read More
11 Jun 2013

UCB to collaborate with CRELUX and 4SC Discovery to meet unmet needs in neurology

Read More
10 Jun 2013

UCB highlights new data from its immunology portfolio at EULAR 2013

Read More
29 May 2013

UCB to secure long-term partnership with UNITHER Pharmaceuticals for its Rochester manufacturing facility

Read More
24 May 2013

Transparency notification of The Capital Group Companies Inc.

Read More
17 May 2013

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

Read More
16 May 2013

UCB and IBM Collaborate to Personalize Care for Epilepsy Patients

Read More
9 May 2013

Acquisition of own shares (09 05)

Read More
Subscribe to